Results 111 to 120 of about 263,787 (314)

Under which realistic circumstances is hrHPV self‐sampling increasing cervical screening effectiveness in a partly vaccinated population? A modelling study

open access: yesInternational Journal of Cancer, EarlyView.
What's New? Offering the option of self‐sampling in cervical cancer screening programs could increase participation. However, it could also prompt participants to switch from clinician‐collecting sampling, which has demonstrated higher testing sensitivity and lower loss to follow‐up.
Sylvia Kaljouw   +4 more
wiley   +1 more source

Spatial evidence for carcinoma in situ (CIS) as an entity in human papillomavirus (HPV)‐associated tonsillar squamous cell carcinoma (TSCC)

open access: yesInternational Journal of Cancer, EarlyView.
What's New? Human papillomavirus (HPV)‐associated tonsillar squamous cell carcinoma (TSCC) is suspected of originating from tonsillar crypts, where HPV can persist in latent form. Detection is further complicated by the possible absence of premalignant stages, namely carcinoma in situ (CIS). Here, the authors investigated tumor origin in HPV‐associated
Tobias Näsman   +3 more
wiley   +1 more source

Prognostic Value of Radiologic Extranodal Extension in Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma [PDF]

open access: hybrid, 2019
Boeun Lee   +6 more
openalex   +1 more source

Risk of cancer among individuals with a history of bacterial sexually transmitted infections: A population‐based study in Alberta, Canada

open access: yesInternational Journal of Cancer, EarlyView.
What's New? While previous studies have identified the carcinogenicity of viral agents such as HIV, the role of bacterial sexually transmitted infections in carcinogenesis remains understudied despite them similarly causing chronic inflammation.
Hina M. Qureshi   +10 more
wiley   +1 more source

Controlled trial of cervical cancer screening frequency among human‐papillomavirus‐vaccinated women

open access: yesInternational Journal of Cancer, EarlyView.
What's New? Since the introduction of the human papillomavirus (HPV) vaccine in 2006, vaccine‐type infections have declined markedly. As nonvaccine HPV types generally carry lower oncogenic potential, this shift warrants reevaluation of cervical screening regimens.
Mònica Ortega Llobet   +10 more
wiley   +1 more source

Skin and Mucosal Human Papillomavirus Seroprevalence in Persons with Fanconi Anemia [PDF]

open access: diamond, 2015
Rachel A. Katzenellenbogen   +7 more
openalex   +1 more source

Prevalence of Epstein–Barr virus, Human Papillomavirus and Porphyromonas Gingivalis in Oral Cancer

open access: green, 2021
Mona Ghazi   +9 more
openalex   +2 more sources

Home - About - Disclaimer - Privacy